328 related articles for article (PubMed ID: 28378389)
21. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
Pinto AK; Jamieson AM; Raulet DH; Hill AB
J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
[TBL] [Abstract][Full Text] [Related]
22. Human tumor-derived exosomes down-modulate NKG2D expression.
Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
[TBL] [Abstract][Full Text] [Related]
23. Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?
Jonjić S; Polić B; Krmpotić A
Eur J Immunol; 2008 Nov; 38(11):2952-6. PubMed ID: 18979514
[TBL] [Abstract][Full Text] [Related]
24. Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen.
Keppler SJ; Aichele P
Eur J Immunol; 2011 Nov; 41(11):3176-86. PubMed ID: 21830209
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-Mediated Activation of NK Cells during Viral Infection.
Freeman BE; Raué HP; Hill AB; Slifka MK
J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
[TBL] [Abstract][Full Text] [Related]
26. The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.
Arapović J; Arapović M; Golemac M; Traven L; Tomac J; Rumora D; Ražić E; Krmpotić A; Jonjić S
Med Microbiol Immunol; 2015 Jun; 204(3):335-44. PubMed ID: 25809566
[TBL] [Abstract][Full Text] [Related]
27. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
[TBL] [Abstract][Full Text] [Related]
28. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
[TBL] [Abstract][Full Text] [Related]
29. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Verneris MR; Karimi M; Baker J; Jayaswal A; Negrin RS
Blood; 2004 Apr; 103(8):3065-72. PubMed ID: 15070686
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.
Lang PA; Lang KS; Xu HC; Grusdat M; Parish IA; Recher M; Elford AR; Dhanji S; Shaabani N; Tran CW; Dissanayake D; Rahbar R; Ghazarian M; Brüstle A; Fine J; Chen P; Weaver CT; Klose C; Diefenbach A; Häussinger D; Carlyle JR; Kaech SM; Mak TW; Ohashi PS
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1210-5. PubMed ID: 22167808
[TBL] [Abstract][Full Text] [Related]
31. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
32. NKG2D Signaling: The Immune Subversive Side of HDAC3.
Folgueras AR; Gonzalez S; López-Soto A
Trends Immunol; 2017 Mar; 38(3):151-153. PubMed ID: 28089218
[TBL] [Abstract][Full Text] [Related]
33. NKG2D Promotes B1a Cell Development and Protection against Bacterial Infection.
Lenartić M; Jelenčić V; Zafirova B; Ožanič M; Marečić V; Jurković S; Sexl V; Šantić M; Wensveen FM; Polić B
J Immunol; 2017 Feb; 198(4):1531-1542. PubMed ID: 28087665
[TBL] [Abstract][Full Text] [Related]
34. Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.
Dandekar AA; O'Malley K; Perlman S
J Virol; 2005 Aug; 79(15):9388-96. PubMed ID: 16014902
[TBL] [Abstract][Full Text] [Related]
35. Functions of NKG2D in CD8
Prajapati K; Perez C; Rojas LBP; Burke B; Guevara-Patino JA
Cell Mol Immunol; 2018 May; 15(5):470-479. PubMed ID: 29400704
[TBL] [Abstract][Full Text] [Related]
36. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
[TBL] [Abstract][Full Text] [Related]
37. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
Groh V; Rhinehart R; Randolph-Habecker J; Topp MS; Riddell SR; Spies T
Nat Immunol; 2001 Mar; 2(3):255-60. PubMed ID: 11224526
[TBL] [Abstract][Full Text] [Related]
38. Murine cytomegalovirus regulation of NKG2D ligands.
Lenac T; Arapović J; Traven L; Krmpotić A; Jonjić S
Med Microbiol Immunol; 2008 Jun; 197(2):159-66. PubMed ID: 18259774
[TBL] [Abstract][Full Text] [Related]
39. Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.
Stadnisky MD; Xie X; Coats ER; Bullock TN; Brown MG
Blood; 2011 May; 117(19):5133-41. PubMed ID: 21436069
[TBL] [Abstract][Full Text] [Related]
40. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.
Gründemann C; Schwartzkopff S; Koschella M; Schweier O; Peters C; Voehringer D; Pircher H
Eur J Immunol; 2010 May; 40(5):1303-14. PubMed ID: 20201037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
